Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Modulation of Gut Microbiota by Essential Oils and Inorganic Nanoparticles: Impact in Nutrition and Health Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

May 2, 2025

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-05-02

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was reviewed?

This review evaluated recent scientific literature concerning the modulation of gut microbiota by essential oils (EOs) and inorganic nanoparticles (NPs), exploring their potential impacts on human nutrition and health. Specifically, it discussed the interactions among gut microbiota, inorganic nanoparticles, such as silver (Ag), titanium dioxide (TiO₂), zinc oxide (ZnO), and silicon dioxide (SiO₂), and various EOs derived from fruits, herbs, and medicinal plants. The review provided insights into the mechanisms through which EOs and nanoparticles modulate gut microbiota, their metabolic products such as short-chain fatty acids (SCFAs), and implications for gut inflammation and systemic health effects.

Who was reviewed?

The review analyzed evidence from various animal models (rodents and pigs), in vitro bacterial cultures, and selected human studies that examined interactions between gut microbiota and exposure to essential oils or nanoparticles. The organisms primarily considered included common gut bacteria from the Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria phyla, along with pathogenic strains such as Escherichia coli, Clostridium perfringens, Salmonella enterica, and Candida albicans.

What were the most important findings?

The review highlighted essential oils’ potent antimicrobial and anti-inflammatory properties, which can beneficially modulate gut microbiota by reducing pathogenic and inflammatory bacterial populations. Notably, bioactive compounds such as d-limonene, carvacrol, thymol, and various polyphenols exhibited substantial modulation of gut microbial communities, positively influencing gut homeostasis and metabolic health. Essential oils also showed capacity for increasing beneficial bacterial taxa, Lactobacilli, and enhancing SCFA production, critical for maintaining gut integrity and reducing inflammation.

Conversely, inorganic nanoparticles generally induced significant microbiota dysbiosis, characterized by decreased beneficial taxa like Firmicutes and Lactobacilli, and increased pathogenic or pro-inflammatory taxa like Proteobacteria. Specifically, silver and titanium dioxide nanoparticles significantly altered gut microbial balance, increasing gut inflammation and oxidative stress markers, while zinc oxide and silicon dioxide nanoparticles negatively impacted gut microbiota diversity and barrier function at higher exposures. However, nanoparticles could also be beneficial when functionalized with essential oils, demonstrating enhanced antimicrobial effects against pathogens, although their long-term safety profiles remain unclear.

What are the greatest implications of this review?

The greatest implications of this review lie in its recognition of essential oils as promising modulators of gut microbiota, potentially useful in managing gut dysbiosis and inflammatory conditions. Additionally, understanding the detrimental effects of nanoparticles on gut microbiota underscores the need for careful assessment of their dietary and therapeutic applications, particularly considering their prevalence in daily consumer products. Moreover, the potential synergistic or antagonistic interactions between essential oils and nanoparticles could lead to novel therapeutic approaches or unintended health consequences, highlighting an urgent need for further comprehensive research into their combined effects on gut microbiome health.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.